Apr 01, 2019
Houston Physicians Embrace New 3-Minute Magnetic Brain Stimulation to Combat Depression
Mar 27, 2019
FDA Clears the Cervella Cranial Electrotherapy Stimulator for Treatment of Anxiety, Insomnia, and Depression
Mar 22, 2019
Watchdog Group, CCHR, to OBGYN Conference: Prevent Psychiatric Drugging of the Preborn
Feb 26, 2019
JayMac Pharmaceuticals' EnBrace HR(TM) Clinical Study Finds Rx Prenatal Vitamin Treats and Prevents Depression in Women Before and During Pregnancy
Feb 14, 2019
Brain & Behavior Research Foundation Applauds FDA Expert Panel Decision to Recommend Approval of New Depression Treatment
Jan 30, 2019
Researchers Find Antidepressants Significantly Increase Risk of Gastrointestinal, Intracranial Bleeding
Nov 14, 2018
Fervent Pharmaceuticals Completes Clinical Trial For Promising New Post-Menopausal Therapy Treating Vasomotor Symptoms
Oct 08, 2018
Shining a Light on Depression - How Infrared Light Can Treat Depression
Aug 31, 2018
Analysis finds investigational medication reduced postpartum depression symptoms in clinical trial
Jul 17, 2018
Eisai Inc. Announces Positive Topline Results from CAMELLIA-TIMI 61, a Large-Scale Cardiovascular Outcome Trial for the Anti-Obesity Agent BELVIQ®
Jun 21, 2018
CCHR's Psychotropic Drug Awareness Campaign Extends to Suicide Warning
Apr 10, 2018
Global Generalized Anxiety Disorder Market is Estimated to Grow at 2.5% CAGR to Reach $7.5 Billion by 2023
Mar 07, 2018
Pregnant Women Taking Antidepressants Encouraged to Report Autism Effects in Infants to Mental Health Watchdog
Feb 28, 2018
CCHR Says Suspected Florida School Shooter Should Not Have Been in Reserve Officer Training if Taking Mind-Altering Stimulants
Feb 21, 2018
New Real-World Analysis Published in The Journal of Clinical Psychiatry Illuminates the Significant Economic Toll of Treatment-Resistant Depression on Individuals, Employers and Payers
Feb 19, 2018
Stimulating Hope and Healing With TMS for Depression and Co-Occurring Disorders
Feb 16, 2018
Global Anti-Depressant Drugs Market Expected to Reach $15,983 Million by 2023 - Allied Market Research
Jan 26, 2018
Flow Neuroscience Raises 1.1M USD in Seed Round Lead by Khosla Ventures to Develop a Device to Treat Depression
Dec 28, 2017
New Menopause Therapy from Fervent Pharmaceuticals to Begin Clinical Trial
Dec 27, 2017
NeuroRx Signs Agreement With U.S. Dept. of Veterans Affairs and Baylor College of Medicine for Clinical Trial of First Drug Regimen Targeting Severe Bipolar Depression in Patients With Acute Suicidal Ideation & Behavior (ASIB)